Pharmacokinetics, Safety, and Tolerability of SYN-020
Clinical trial NCT04815993 · COMPLETED
Trial details
- NCT number
- NCT04815993
- Sponsor
- Theriva Biologics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-22
- Primary completion
- 2021-05-18
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.